this post was submitted on 23 May 2025
28 points (100.0% liked)

Medicine Canada

251 readers
9 users here now

A community for Canadian physicians and medical professionals


🍁 While this community is intended for Canadian discussions, you are free to post about other medical systems. We're all in this together :)



Related Communities

For better links and descriptions, see the pinned post in the Medical Community Hub (!medicine@lemmy.world)


Rules

  1. No requests for professional advice or general medical information. Please do not solicit medical advice or share personal health anecdotes about yourself or others.

  2. No promotions, advertisements, surveys, or petitions.

  3. Link to high-quality, original research whenever possible: Posts which rely on or reference scientific data (e.g. an announcement about a medical breakthrough) should link to the original research in peer-reviewed medical journals or respectable news sources as judged by the moderators. Sensationalized titles, misrepresentation of results, or promotion of blatantly bad science may lead to removal.

  4. Act professionally and decently: /r/medicine is a public forum that represents the medical community and comments should reflect this. Please keep disagreement civil and focused on issues.

  5. Protect patient confidentiality. Please anonymize cases and remove any patient-identifiable information.

  6. No memes or low-effort posts: Memes, image links (including social media screenshots), images of text, or other low-effort posts or comments are not allowed.

These rules have been modelled after /r/medicine. While some rules were modified or skipped as this is a much smaller community, we can revisit the rules as we go. Thank you :)

founded 2 years ago
MODERATORS
 

If federal, provincial and territorial governments follow the CDA’s advice, Wegovy would be the first prescription weight loss drug to be covered by public insurance plans.

Provincial governments should pay for the weight-loss drug Wegovy for people who are overweight and have survived a heart attack or stroke, according to a new report from the organization that advises Canadian public drug plans on which new medications to cover.

Canada’s Drug Agency, which released the draft recommendation on Thursday, said taxpayer-funded drug plans should reimburse Wegovy for people with a body mass index of 27 or higher and pre-existing cardiovascular disease because a clinical trial found the once-weekly injection cut their risk of another heart attack, stroke or cardiovascular death by 20 per cent.


From The Globe and Mail via this RSS feed

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here